Summary
F5, Inc. (FFIV) reported solid financial results for the quarter ended December 31, 2025. Total revenues increased by 7.3% year-over-year to $822.5 million, driven by a significant 11.3% surge in product revenues to $410.3 million, primarily due to strong performance in systems. Service revenues also saw a modest increase of 3.6% to $412.2 million. Net income grew by 8.2% to $180.1 million, resulting in diluted earnings per share of $3.10, up from $2.82 in the prior year period. The company's gross margin remained strong at 81.5%. The company successfully integrated the acquisition of CalypsoAI Corp. in September 2025, enhancing its AI security offerings. While F5 continues to invest in research and development and sales and marketing, it also executed a substantial share repurchase program, returning capital to shareholders. Management expressed confidence in the company's liquidity and ability to meet its obligations, with cash and equivalents totaling $1.2 billion at quarter-end. Investors should monitor the ongoing legal proceedings and the potential impact of the previously disclosed Cyber Incident.
Financial Highlights
48 data points| Revenue | $822.47M |
| Cost of Revenue | $151.78M |
| Gross Profit | $670.68M |
| R&D Expenses | $141.16M |
| Operating Expenses | $456.49M |
| Operating Income | $214.19M |
| Net Income | $180.05M |
| EPS (Basic) | $3.12 |
| EPS (Diluted) | $3.10 |
| Shares Outstanding (Basic) | 57.65M |
| Shares Outstanding (Diluted) | 58.16M |
Key Highlights
- 1Total revenues grew 7.3% year-over-year to $822.5 million.
- 2Product revenues increased significantly by 11.3% to $410.3 million, led by a 36.7% rise in systems revenue.
- 3Net income rose 8.2% to $180.1 million, with diluted EPS reaching $3.10.
- 4Gross margin remained robust at 81.5%.
- 5F5 acquired CalypsoAI Corp. in September 2025 to bolster its AI security capabilities.
- 6The company repurchased $301 million of its common stock during the quarter.
- 7Cash and cash equivalents stood at $1.2 billion at the end of the period.